- Home
- SYRE vs VCYT Comparison
SYRE vs VCYT Comparison
Compare SYRE & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SYRE | VCYT |
|---|---|---|
| Founded | 2013 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.6B |
| IPO Year | 2015 | 2013 |
Fundamental Metrics
Financial Performance| Metric | SYRE | VCYT |
|---|---|---|
| Price | $42.53 | $33.11 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 7 |
| Target Price | ★ $60.13 | $45.14 |
| AVG Volume (30 Days) | 636.1K | ★ 845.5K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 164.52 |
| EPS | N/A | ★ 0.82 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $13.48 |
| Revenue Next Year | N/A | $12.67 |
| P/E Ratio | ★ N/A | $40.31 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.91 | $22.61 |
| 52 Week High | $45.76 | $50.71 |
Technical Indicators
Market Signals| Indicator | SYRE | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 56.71 | 43.99 |
| Support Level | $38.36 | $31.22 |
| Resistance Level | $45.57 | $34.89 |
| Average True Range (ATR) | 2.11 | 1.16 |
| MACD | -0.23 | 0.17 |
| Stochastic Oscillator | 56.54 | 42.27 |
Price Performance
Historical ComparisonAbout SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).